Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | Chief Financial Officer | Mar 15, 2024 | Option Exercise | $12.48 | 932 | 11,629 | 2,395 | Mar 19, 2024, 08:01 PM | |
TYRA | Tyra Biosciences, Inc. | Fuhrman Alan | Chief Financial Officer | Sep 15, 2023 | Option Exercise | $12.50 | 1,463 | 18,293 | 1,463 | Sep 19, 2023, 07:27 PM | |
LOXO | Loxo Oncology, Inc. | Fuhrman Alan | Director | Jun 08, 2018 | Sale | $94.71 | 5,250 | 497,230 | 2,625 | Jun 11, 2018, 06:01 PM | |
AMBI | AMBIT BIOSCIENCES CORP | Fuhrman Alan | Chief Financial Officer | Nov 10, 2014 | Option Exercise | $15.00 | 6,309 | 94,635 | 0 | Nov 12, 2014, 05:37 PM |